Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06490900 · ClinicalTrials.gov registry record · NA
Influence of Intermittent Hypoxia on Glycemic Control
A NA study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT06490900 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 18 participants.
The verdict
NCT06490900, a NA study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
The aim of this research project is to determine the effect of intermittent hypoxia on glucose uptake in response to an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
Interventions
- BEHAVIORAL Intermittent hypoxia
- BEHAVIORAL Intermittent normoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-02-05 |
| Est. Completion | 2024-11-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06490900
The ClinicalTrials.gov registry entry for NCT06490900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Intermittent hypoxia is the first listed.
NCT06490900 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06490900 about?
NCT06490900 is a clinical study titled "Influence of Intermittent Hypoxia on Glycemic Control". The aim of this research project is to determine the effect of intermittent hypoxia on glucose uptake in response to an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.
What is the current status of trial NCT06490900?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2021-02-05. Estimated completion is 2024-11-26.
What interventions are being tested in trial NCT06490900?
The interventions under investigation include: Intermittent hypoxia (BEHAVIORAL), Intermittent normoxia (BEHAVIORAL).
Who is sponsoring clinical trial NCT06490900?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.